(11bS)-4,4-Diethyl-2,6-bis(3,4,5-trifluorophenyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium bromide

Catalog No. :
ACGHXD277
CAS No. :
851942-87-5
Molecular Formula :
C38H28BrF6N
Molecular Weight :
692.54

IUPAC Name:4,4-diethyl-2,6-bis(3,4,5-trifluorophenyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium bromide

(11bS)-4,4-Diethyl-2,6-bis(3,4,5-trifluorophenyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium bromide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(11bS)-4,4-Diethyl-2,6-bis(3,4,5-trifluorophenyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium bromide
IUPAC Name4,4-diethyl-2,6-bis(3,4,5-trifluorophenyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium bromide
Molecular FormulaC38H28BrF6N
Molecular Weight692.54
SMILESFC1=C(F)C(F)=CC(C2=CC3=C(C4=C2C[N+](CC)(CC)CC5=C4C6=C(C=C5C7=CC(F)=C(C(F)=C7)F)C=CC=C6)C=CC=C3)=C1.[Br-]
InChI KeyLIFGFOQOHGWNGB-UHFFFAOYSA-M
Synonym(11bS)-4,4-Diethyl-2,6-bis(3,4,5-trifluorophenyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium bromide;3H-Dinaphth[2,1-c:1′,2′-e]azepinium, 4,4-diethyl-4,5-dihydro-2,6-bis(3,4,5-trifluorophenyl)-, bromide (1:1), (11bS)-
CAS No.851942-87-5

Synthetic Route by SureRoute

1. ACGHXD277 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGHXD277 route product structure diagram
    ACGHXD277851942-87-5
Inquiry

2. ACGHXD277 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGHXD277 route product structure diagram
    ACGHXD277851942-87-5
Inquiry

Comments (0)